Navigation Links
WellSpring Pharmaceutical Corp. Names Wendy Shusko as New Chief Operating Officer
Date:10/28/2008

BRADENTON, Fla., Oct. 28 /PRNewswire/ -- WellSpring Pharmaceutical Corporation, a growing North American-based pharmaceutical manufacturer, today announced that Wendy Shusko has been named Chief Operating Officer. Formerly, Ms. Shusko held the position of Chief Financial Officer, having joined the company in early 2000. In her new role as COO, Ms. Shusko will maintain financial responsibilities while broadening her areas of oversight to operations with an initial focus on the newly acquired consumer brands product line.

"WellSpring has been successful in the relaunch of older niche prescription products. We now have the opportunity to show equal success with our new niche consumer products portfolio," said Ms. Shusko. "I am looking forward to the challenge and am pleased to be able to take part in WellSpring's continued growth."

Ms. Shusko has over twenty years' experience of combined financial and operational experience with sixteen of those years in the pharmaceutical industry. From 1992 until joining the WellSpring team, Ms. Shusko worked in various management and financial capacities for Roberts Pharmaceutical Corporation, an international, multi-faceted pharmaceutical company, including Director of Finance and Financial Operations.

"WellSpring's success thus far can be attributed to driven efforts toward a common vision. I am now asking Ms. Shusko to apply her experience and skills to operations with the anticipation that we will continue that trend in the years to come," said Dr. Robert A. Vukovich, WellSpring's CEO and Chairman.

About the Company

WellSpring Pharmaceutical Corp has made the development, marketing and sales of new and novel prescription and OTC drug products its strategic focus. WellSpring's prescription drug products include Dyrenium (R) (diuretic) and Dibenzyline (R) (anti-hypertension) which are marketed in the US. The firm is an active acquirer of pharmaceutical brands and enhances their value throu
'/>"/>

SOURCE WellSpring Pharmaceutical Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. WellSpring Pharmaceutical Corp. Acquires Consumer Product Brands from McNeil Consumer Healthcare -- Deal Enhances US and Canadian Pharmaceutical Business
2. Mylan Commences Tender Offers and Consent Solicitations for Its 5.750% Senior Notes Due 2010 and 6.375% Senior Notes Due 2015 in Connection With Its Proposed Acquisition of Mercks Generic Pharmaceutical Business
3. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
4. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
5. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
6. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
7. National Pharmaceutical Council Announces New Strategic Focus, Search for New Leadership
8. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Coreg(R)
9. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
10. Par Pharmaceutical Files Form 10-K for 2006 -- Company to Hold First Analysts Meeting September 28, 2007
11. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/8/2009)...ADELPHIA, Nov. 8 The Am...he prevention and wellness provisions in the healt..., "With passage of this bill, the House takes impo...important insurance reforms and moving our health ...to one that focuses on keeping people healthy," sa...
(Date:11/8/2009)...er Costs and Crushing Taxes Nail Nation,s Job Crea...re/ -- In response to U.S. House passage of the he...ntrepreneurship Council (SBE Council) president &a...ent: ,, "Make no mistake, those voting for H.R...ith higher costs and crushing taxes and penalties....
(Date:11/8/2009)... Freeze-drying of biopharmaceutical...ga, Ontario facility. , ...lner, President and CEO of Therapure Biopharma Inc...ery of a commercial scale pharmaceutical grade fre...eze drying (lyophilization) available for contract...
(Date:11/8/2009)...ion,s largest network of Hispanic health advocates...orm in 2009 ,, WASHINGTON, Nov. 7 /PRNewswire-...tatives showed they have heard the voice of Americ... for America Act. Now the Senate must deliver, wit...re reform," said Dr. Jane L. Delgado, President an...
(Date:11/8/2009)...P Praises House Passage of Health Care Reform Bill...icare, improve coverage for all Americans ,, C...he United States House of Representatives passed b...egislation that would strengthen Medicare for seni...that prices millions of Americans out of affordabl...
Breaking Medicine News(10 mins):Health News:APHA Applauds Prevention and Wellness Provisions in House Health Reform Bill 2Health News:Therapure Biopharma Inc. Announces Delivery of its First Commercial-Scale Lyophilizer 2Health News:National Alliance for Hispanic Health President and CEO Applauds House Action, Calls on Senate to Pass Health Reform in 2009 2Health News:AARP Illinois Key Vote News Alert 2Health News:AARP Illinois Key Vote News Alert 3
...at the cox-2 inhibitor celecoxib, a common pain re...k of the most common cause of brain damage in pre...p blood vessels in a part of the brain that in pre...lastingly affected by cerebral palsy, mental retar...
...e risk of a type of kidney malignancy called renal...hers at Brigham and Women's Hospital in Boston fou...alcoholic beverage a day were about 30 percent les...nd other researchers reviewed data from 12 studies...
...s generally suffer in silence, cough up more money...th mixed results. And here comes the news tha...ring warranty on its workmanship, charging a flat ...nd the insurer another bill. Well the Geisin...
... a health authority in St. John's, Canada, has apo...tests that may have affected the care of hundreds...the Eastern Health Regional Authority agreed that ... that we didn't simply refer to it earlier,' Tille...
...of Cincinnati have developed a model that could im... helping physicians combine current clot-busting ...othermia. It is already known that lowerin...pproved stroke medication is an enzyme called tiss...
...s of the four sick public sector pharmaceutical an...overnments , the railways and the armed forces hav...hem profit making units. According to the ... Hindustan Organic Chemicals Limited have been rev...
Other Medicine News:Health News:Common Pain Killer may Reduce the Risk of Brain Damage in Premature Babies 2Health News:Common Pain Killer may Reduce the Risk of Brain Damage in Premature Babies 3Health News:US Hospital Group Offers Warranty on Surgeries 2Health News:US Hospital Group Offers Warranty on Surgeries 3Health News:Faulty Hormone Tests Compromised Healthcare Of Breast Cancer Patients 2Health News:Researchers Develop Model That Aids in Treating Stroke Patients 2Health News:Government Hospitals to the Rescue of Loss-making Pharma Companies 2
(Date:11/6/2009)...-FirstCall/ -- Keryx Biopharmaceuticals, Inc. (Nas...y, November 10, 2009 at 8:30 a.m. EST to discuss t...ss outlook for the remainder of 2009. Ron Bentsur...t the call. Keryx will announce its financial res...ed prior to the call. ,, In order to participat...
(Date:11/6/2009)...FirstCall/ -- Caraco Pharmaceutical Laboratories, ...methamine ophthalmic solution, 0.5% following a fi...ion (FDA) for Sun Pharma,s Abbreviated New Drug Ap...c solution on the first day following patent expir...ly equivalent to Acular® Ophthalmic Solution,...
(Date:11/5/2009)... 5 Transcept Pharmaceuti...tical company focused on the development and comme...important therapeutic needs in the field of neuros... teleconference with management to discuss third q...r 12, 2009, at 5:00 p.m. Eastern Standard Time. F...
Breaking Medicine Technology:Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Third Quarter 2009 Financial Results on Tuesday, November 10, 2009 at 8:30 a.m. EST 2Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Acular(R) Opthalmic Solution 2Transcept Pharmaceuticals to Report Third Quarter 2009 Results and Host Conference Call on November 12 2Gene findings revealing reasons for neuroblastoma risk 49275 1Gene findings revealing reasons for neuroblastoma risk 49275 2Study supports validity of test that indicates widespread unconscious bias 49273 1Study supports validity of test that indicates widespread unconscious bias 49273 2Roux en Y weight loss surgery raises kidney stone risk 49271 1Roux en Y weight loss surgery raises kidney stone risk 49271 2
... foot and ankle or deformity and leg lengthening c...ternal Fixation components are designed to reduce ...lexity of intra-operative and post-operative frame...ractors and hinges eliminate the need to stock lar...
Gold Standard Interference Screw
...g hip surgery. The Stulberg Hip Positioner is use... hip and revision surgery. It is designed to attac...isting table adapters. The upright pads are made ... and are sealed with a washable coating. The coati...
...fixation system for small bone orthopedic osteotom...ion and a superior screw and plating system in one...ag screws used for the fixation of the hand and fo...ed to overdrill the proximal segment while the low...
Medicine Products: